The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
C-Reactive Protein and the Risk of Developing Hypertension
Abstract
CONTEXT: Although it has been hypothesized that hypertension is in part an inflammatory disorder, clinical data linking inflammation with incident hypertension are scarce. OBJECTIVE: To examine whether C-reactive protein levels, a marker of systemic inflammation, are associated with incident hypertension. DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study that began in 1992 of 20 525 female US health professionals aged 45 years or older who provided baseline blood samples with initially normal levels of blood pressure (BP) (systolic BP <140 mm Hg and diastolic BP <90 mm Hg, and no history of hypertension or antihypertensive medications) and then followed up for a median of 7.8 years for the development of incident hypertension. Plasma C-reactive protein levels were measured and baseline coronary risk factors were collected. MAIN OUTCOME MEASURE: Incident hypertension, defined as either a new physician diagnosis, the initiation of antihypertensive treatment, or self-reported systolic BP of at least 140 mm Hg or a diastolic BP of at least 90 mm Hg. RESULTS: During follow-up, 5365 women developed incident hypertension. In crude models, the relative risks (RRs) and 95% confidence intervals (CIs) of developing hypertension from the lowest (referent) to the highest levels of baseline C-reactive protein were 1.00, 1.25 (95% CI, 1.14-1.40), 1.51 (95% CI, 1.35-1.68), 1.90 (95% CI, 1.72-2.11), and 2.50 (95% CI, 2.27-2.75) (linear trend P<.001). In fully adjusted models for coronary risk factors, the RRs and 95% CIs were 1.00, 1.07 (95% CI, 0.95-1.20), 1.17 (95% CI, 1.04-1.31), 1.30 (95% CI, 1.17-1.45), and 1.52 (95% CI, 1.36-1.69) (linear trend P<.001). C-reactive protein was significantly associated with an increased risk of developing hypertension in all prespecified subgroups evaluated, including those with very low levels of baseline BP, as well as those with no traditional coronary risk factors. Similar results were found when treating C-reactive protein as a continuous variable and controlling for baseline BP. CONCLUSION: C-reactive protein levels are associated with future development of hypertension, which suggests that hypertension is in part an inflammatory disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 2×
“Overall, there were 7065, 6920, and 6540 women with C-reactive protein levels of less than 1, 1 to less than 3, and 3 or more mg/L, respectively, cut points recently set forth in clinical guidelines.(25)”
BackgroundMethodSelf-citationRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citationYudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Verma, S., Wang, C.-H., Li, S.-H., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R.-K., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,054
COLDITZ, G. A., MARTIN, P., STAMPFER, M. J., WILLETT, W. C., SAMPSON, L., ROSNER, B., HENNEKENS, C. H., & SPEIZER, F. E. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114319 · Cited by 992 · cited 2×
“To address this potential limitation, we performed a separate study in which an 86% validation rate for selfreported hypertension was observed, consistent with other studies.(36,37) For example, in a comparable population in the Nurses’ Health Study, 99% of women who reported high BP confirmed their diagnosis based on…”
ResultVenugopal, S. K., Devaraj, S., Yuhanna, I., Shaul, P., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 853
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
Blood Pressure and Inflammation in Apparently Healthy Men
Chae, C. U., Lee, R. T., Rifai, N., & Ridker, P. M. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.399 · Cited by 716
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Verma, S., Li, S.-H., Badiwala, M. V., Weisel, R. D., Fedak, P. W. M., Li, R.-K., Dhillon, B., & Mickle, D. A. G. (2002) · Circulation · doi:10.1161/01.cir.0000015126.83143.b4 · Cited by 634
Sesso, H. D., Stampfer, M. J., Rosner, B., Hennekens, C. H., Gaziano, J. M., Manson, J. E., & Glynn, R. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.801 · Cited by 599
Self-citationVascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586 · cited 1×
“Inflammation has been shown to correlate with endothelial dysfunction(17) and relate to the renin-angiotensin system.(18) As a result, it has been hypothesized that hypertension may be in part an inflammatory disorder.”
BackgroundC-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle
Wang, C.-H., Li, S.-H., Weisel, R. D., Fedak, P. W. M., Dumont, A. S., Szmitko, P., Li, R.-K., Mickle, D. A. G., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000061916.95736.e5 · Cited by 545
Bermudez, E. A., Rifai, N., Buring, J., Manson, J. E., & Ridker, P. M. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000029781.31325.66 · Cited by 469
Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein
Ridker, P. M., Hennekens, C. H., Rifai, N., Buring, J. E., & Manson, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.7.713 · Cited by 443
Ockene, I. S., Matthews, C. E., Rifai, N., Ridker, P. M., Reed, G., & Stanek, E. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.444 · Cited by 411
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects
Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Price, N., Dinges, D. F., & Mullington, J. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.426 · Cited by 410
Self-citationSurvey of C-reactive protein and cardiovascular risk factors in apparently healthy men
Rohde, L. E. P., Hennekens, C. H., & Ridker, P. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00491-9 · Cited by 349
Baseline Characteristics of Participants in the Women's Health Study
Rexrode, K. M., Lee, I.-M., Cook, N. R., Hennekens, C. H., & Buring, J. E. (2000) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460900318911 · Cited by 310
Is C-reactive protein an independent risk factor for essential hypertension?
Bautista, L. E., López-Jaramillo, P., Vera, L. M., Casas, J. P., Otero, A. P., & Guaracao, A. I. (2001) · Journal of Hypertension · doi:10.1097/00004872-200105000-00004 · Cited by 299
Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men
Skoog, T. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2805 · Cited by 275
Yamada, S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.12.1183 · Cited by 235
The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review
Dawson, S., & Henney, A. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90014-8 · Cited by 189
Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population
Poli, K. A., Tofler, G. H., Larson, M. G., Evans, J. C., Sutherland, P. A., Lipinska, I., Mittleman, M. A., Muller, J. E., D’Agostino, R. B., Wilson, P. W. F., et al. (2000) · Circulation · doi:10.1161/01.cir.101.3.264 · Cited by 176
Giles, W. H., Croft, J. B., Keenan, N. L., Lane, M. J., & Wheeler, F. C. (1995) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30468-9 · Cited by 138
Engström, G., Janzon, L., Berglund, G. L., Lind, P., Stavenow, L., Hedblad, B., & Lindgärde, F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000041842.43905.f3 · Cited by 136
Validity of physicians' self-reports of cardiovascular disease risk factors
Klag, M. J., He, J., Mead, L. A., Ford, D. E., Pearson, T. A., & Levine, D. M. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90074-e · Cited by 95
Ford, E. S., & Giles, W. H. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00143-2 · Cited by 67
PAI-1 in human hypertension: relation to hypertensive groups
Srikumar, N., Brown, N. J., Hopkins, P. N., Jeunemaı̂tre, X., Hunt, S. C., Vaughan, D. E., & Williams, G. H. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02952-7 · Cited by 40
Cited by
Irwin, M. R., Olmstead, R., & Carroll, J. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.014 · Cited by 2,085
“Increases in circulating markers of inflammation, such as high sensitivity C-reactive protein (CRP) and interleukin-6 (IL-6), predict cardiovascular events (10,11), hypertension (12), weight gain in older adults”
BackgroundObesity and inflammation: the linking mechanism and the complications
Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A., & Abed, Y. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.58928 · Cited by 1,982
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
Miller, G. E., Chen, E., & Parker, K. J. (2011) · Psychological Bulletin · doi:10.1037/a0024768 · Cited by 1,785
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324
Metadata
- Authors
- Sesso, H. D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-12-10
- Volume
- 290
- Issue
- 22
- Pages
- 2945
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2015511799
- Cited by
- 1,004
- References
- 35
- FWCI
- 33.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.